Topic

stock plummet

A collection of 1 issue

Neumora Shares Dive as Depression Drug Fails Phase 3 Trial

Neumora Therapeutics shares nosedived after its promising depression drug failed in a crucial Phase 3 trial, impacting investor confidence. Learn more about the implications.